Related Experiment Video
Updated: Jun 26, 2026
11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Genetical metabolomics: closing in on phenotypes.
1Laboratory of Genetics, Wageningen University, Arboretumlaan 4, NL-6703 BD Wageningen, The Netherlands. joost.keurentjes@wur.nl
Current Opinion in Plant Biology
|January 24, 2009
Summary
Linking plant genotype to phenotype is key. Metabolism and complex networks drive plant diversity, with new tech enhancing our understanding for multidisciplinary plant science.
Area of Science:
- Plant Biology
- Genetics
- Metabolomics
Background:
- Linking genotypic variation to natural variation in plant development and adaptive traits is a major goal in plant biology.
- Phenotypic diversity is underpinned by complex, interacting networks.
- Plant metabolism plays a crucial role in regulatory mechanisms due to its rich and variable content profiles.
Purpose of the Study:
- To explore the link between genotypic variation and phenotypic diversity in plants.
- To highlight the role of metabolism in plant regulatory mechanisms.
- To emphasize the benefits of integrated multidisciplinary approaches in modern plant science.
Main Methods:
- Utilizing technological advances in detecting and quantifying biochemical content.
- Employing novel experimental approaches to accelerate data generation.
- Integrating data from various disciplines to understand regulatory mechanisms.
Main Results:
- Recent studies reveal complex interacting networks underlying phenotypic diversity.
- Metabolic content profiles are highly variable and play a major role in regulation.
- Technological and experimental advancements have significantly increased understanding.
Conclusions:
- Modern plant science can greatly benefit from integrated multidisciplinary approaches.
- Understanding the interplay between genotype, metabolism, and phenotype is crucial for plant biology.
- Continued advancements in technology and methodology are accelerating discoveries in plant science.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...